We were delighted to speak with Dr Thomas V Johnson (Wilmer Eye Institute, Johns Hopkins University, Baltimore, MD, USA) and find out his thoughts on the current status and future challenges of stem cell-based retinal ganglion cell transplantation in glaucoma therapy, and the challenges and opportunities of the online format of this year’s virtual meeting.
Questions
- Could you tell us a little about the current status and future challenges of stem cell-based retinal ganglion cell transplantation in glaucoma therapy? (00:16)
- What are the challenges and opportunities of the online format of this year’s AGS meeting? (03:12)
Speaker Disclosure: Thomas V Johnson has no financial or non-financial relationships or activities to declare in relation to this video interview.
Support: Interview and filming supported by Touch Medical Media Ltd.
Filmed in coverage of AGS 2021.
